Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR)

CUSIP: 92915B106

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
55,632,823
Total 13F shares
10,403,150
Share change
+10,166,288
Total reported value
$225,137,498
Price per share
$21.90
Number of holders
35
Value change
+$219,950,498
Number of buys
34

Quarterly Holders Quick Answers

What is CUSIP 92915B106?
CUSIP 92915B106 identifies VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2015

As of 31 Dec 2015, Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,403,150 shares. The largest 10 holders included FMR LLC, BROOKSIDE CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, Partner Fund Management, L.P., GOLDMAN SACHS GROUP INC, JANUS CAPITAL MANAGEMENT LLC, EVENTIDE ASSET MANAGEMENT, LLC, Casdin Capital, LLC, DEERFIELD MANAGEMENT CO, and BlackRock Fund Advisors. This page lists 35 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.